NewSquare Capital LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
NewSquare Capital LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$849
-99.0%
6
-98.8%
0.00%
-100.0%
Q1 2023$85,359
-0.6%
5070.0%0.01%
-9.1%
Q4 2022$85,840
-8.7%
507
+0.4%
0.01%
-8.3%
Q3 2022$94,000
+14.6%
5050.0%0.01%
+9.1%
Q2 2022$82,000
+8100.0%
505
+10000.0%
0.01%
Q1 2022$1,000
-50.0%
5
-16.7%
0.00%
Q4 2021$2,0000.0%60.0%0.00%
Q3 2021$2,000
+100.0%
60.0%0.00%
Q2 2021$1,0000.0%60.0%0.00%
Q1 2021$1,000
-99.8%
6
-99.9%
0.00%
-100.0%
Q4 2019$641,0006,9250.11%
Other shareholders
REPLIGEN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders